COVID-19 Vaccination, Hospitalization Rates, and Mortality Differ Between People with Diagnosed Immune Mediated Inflammatory Disease and the General Population: A Population-Based Study
Although COVID-19 vaccination reduced the risk of Hosp-C and death in both pIMIDs and comparators, pIMIDs remained at higher risk for both. Since SARS-CoV-2 is now endemic, these findings may inform ongoing vaccination recommendations.
Authors
- Jessica Widdifield (ORCID: https://orcid.org/0000-0002-7464-0460)
- Çharles N. Bernstein (ORCID: https://orcid.org/0000-0001-8041-3574)
- Carole Taylor
- Carol Hitchon (ORCID: https://orcid.org/0000-0001-5547-3268)
- Gilaad G. Kaplan (ORCID: https://orcid.org/0000-0003-2719-0556)
- CHRISTINE A. PESCHKEN (ORCID: https://orcid.org/0000-0002-4269-5213)
- Diane Lacaille (ORCID: https://orcid.org/0000-0002-4065-4151)
- Ruth Ann Marrie (ORCID: https://orcid.org/0000-0002-1855-5595)
Institutions
- Manitoba Health (CA)
- Dalhousie University (CA)
- Sunnybrook Health Science Centre (CA)
- University of Calgary (CA)
- Nova Scotia Health Authority (CA)
- Research Canada (CA)
- Arthritis Research Centre of Canada (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Vaccines
- Published
- 2025-11-02
- DOI
- https://doi.org/10.3390/vaccines13111130
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00